Grant: Operating Grant - Priority Announcement: Infection and Immunity (Bridge Funding)
McGill University
$100,000.00
Functional characterization of nleA, a novel Type III secreted virulence factor of enterohemorrhagic and enteropathogenic E. coli
FY 2008-09
Summary
Harmless strains of E. coli colonize the human intestinal tract hours after birth and are part of our normal intestinal flora. However, pathogenic E. coli strains, such as enteropathogenic E. coli (EPEC) and enterohemorrhagic (EHEC) E. coli have evolved mechanisms to induce serious disease in humans and are a widespread and an increasingly important public health issue. EPEC is a diarrheal pathogen that kills several hundred thousand children a year in developing countries, while EHEC is more prevalent in developed countries, and causes diarrheal disease with potentially fatal complications. Despite the health risks posed by these bacteria, there are few therapies that effectively treat these infections, indicating a significant need to further examine how these pathogens cause disease. We have identified a bacterial protein, NleA, that is present in EPEC and EHEC but absent from harmless E. coli. Furthermore, deletion of this protein in disease-causing bacteria greatly reduces their capacity to cause disease. The experiments in this proposal are aimed at understanding how NleA works and what its role is in disease. We anticipate that these studies may provide a starting point for the development of new treatments for EPEC and EHEC infections.
Department
Program
Operating Grant - Priority Announcement: Infection and Immunity (Bridge Funding)
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
187118
Name
Gruenheid Samantha L
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Microbiology & Infectious Diseases
Projecttitle
Functional characterization of nleA, a novel Type III secreted virulence factor of enterohemorrhagic and enteropathogenic E. coli
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Operating Grant - Priority Announcement: Infection and Immunity (Bridge Funding)
Keyworddelim
Bacterial Pathogenesis; Cell Biology; Enterohemorrhagic E. Coli; Enteropathogenic E. Coli; Protein-Protein Interaction; Virulence Factor
Abstract
Harmless strains of E. coli colonize the human intestinal tract hours after birth and are part of our normal intestinal flora. However, pathogenic E. coli strains, such as enteropathogenic E. coli (EPEC) and enterohemorrhagic (EHEC) E. coli have evolved mechanisms to induce serious disease in humans and are a widespread and an increasingly important public health issue. EPEC is a diarrheal pathogen that kills several hundred thousand children a year in developing countries, while EHEC is more prevalent in developed countries, and causes diarrheal disease with potentially fatal complications. Despite the health risks posed by these bacteria, there are few therapies that effectively treat these infections, indicating a significant need to further examine how these pathogens cause disease. We have identified a bacterial protein, NleA, that is present in EPEC and EHEC but absent from harmless E. coli. Furthermore, deletion of this protein in disease-causing bacteria greatly reduces their capacity to cause disease. The experiments in this proposal are aimed at understanding how NleA works and what its role is in disease. We anticipate that these studies may provide a starting point for the development of new treatments for EPEC and EHEC infections.
Competitiondate
200903
Approvedterm2
1 yr 0 mth
Pinamesdelim
Gruenheid, Samantha L
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~